News

Latest Posts
Opdivo Shows Better Results Than Yervoy in Melanoma Patients

Opdivo Shows Better Results Than Yervoy in Melanoma Patients

Dr. Jeffrey Weber of NYU Langone Health recently reported in Targeted Oncology that three year-data from the phase II CheckMate 238 clinical trial reveal that nivolumab (Opdivo) shows superiority over ipilimumab (Yervoy) in patients with resected stage III or IV...

subscribe

CNS Summit
subscribe

Pin It on Pinterest